St. Jude Medical, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 105   

Articles published

STJ 65.87 -0.47 (-0.71%)
price chart
St. Jude Medical gives downbeat profit outlook
St. Jude Medical Inc. warned of foreign-exchange pressures this year as its sales and profit for the most recent period matched the company's preliminary results that were released earlier this month.
St. Jude Medical, Inc. (STJ) Releases FY15 Earnings Guidance
St. Jude Medical logo St. Jude Medical, Inc. (NYSE:STJ) issued an update on its FY15 earnings guidance on Wednesday morning.
St. Jude Medical Outlook Hit by Foreign-Exchange Pressures  Wall Street Journal
St. Jude Medical Reports Fourth Quarter and Full-Year 2014 Results  MarketWatch
St. Jude Medical, Inc. (STJ) Releases Q1 Earnings Guidance
St. Jude Medical logo St. Jude Medical, Inc. (NYSE:STJ) updated its first quarter earnings guidance on Wednesday.
St. Jude Medical Q4 Adj. Profit Tops View - Quick Facts
Adjusted net earnings attributable to St. Jude Medical, Inc. for the latest fourth quarter was $298 million or $1.03 per share, up from $294 million or $0.99 per share in the year-ago period.
St. Jude Medical Announces FDA Approval of FlexAbility Ablation Catheter
PAUL, Minn., Jan 27, 2015 (BUSINESS WIRE) -- St. Jude Medical, Inc. STJ, -0.71% a global medical device company, today announced U.S.
Company Update: St. Jude Medical Inc (NYSE:STJ) - St. Jude Medical ...  Jutia Group
St. Jude Medical Q4 Results Meet Estimates, But Issues Weak Outlook
Cardiovascular medical devices maker St. Jude Medical, Inc. (STJ: Quote) reported Wednesday a profit for the fourth quarter that doubled from last year, reflecting lower charges and sales growth.
Can St. Jude Medical (STJ) Keep Earnings Streak Alive? - Analyst Blog
Last quarter, the company reported earnings of 97 cents per share, which beat the Zacks Consensus Estimate by a penny. In fact, in all the past four quarters, St. Jude Medical's earnings have outpaced the Zacks Consensus Estimate with an average beat ...
St. Jude Medical Price Target Cut to $74.00 by Analysts at Credit Suisse (STJ)
Analysts at Needham & Company LLC raised their price target on shares of St. Jude Medical from $78.00 to $84.00 and gave the company a �strong-buy� rating in a research note on Friday, January 16th. Finally, analysts at Wedbush set a $77.00 price ...
St. Jude Medical Price Target Lowered to $78.00 at CRT Capital (STJ)
St. Jude Medical, Inc. logo St. Jude Medical (NYSE:STJ) had its price target decreased by CRT Capital from $80.00 to $78.00 in a research report sent to investors on Thursday morning.
St. Jude Medical's "Buy" Rating Reaffirmed at BTIG Research (STJ)
St. Jude Medical, Inc. logo BTIG Research reissued their buy rating on shares of St. Jude Medical (NYSE:STJ) in a research note released on Thursday morning.